14:31 EDT Day One up 11% to $17 after FDA grants accelerated approval
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DAWN:
- Day One Biopharmaceuticals price target raised to $36 from $32 at JPMorgan
- Day One Biopharmaceuticals trading resumes
- Day One Biopharmaceuticals trading halted, volatility trading pause
- Day One Biopharmaceuticals price target lowered to $33 from $35 at Wedbush
- Day One Biopharmaceuticals price target lowered to $40 from $45 at Piper Sandler
